Patel Kavita — SEC insider filings
SEC reporting owner CIK 1670683. 35 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 35 filings on record, filed 2020-12-11 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 32 legs across 18 filings — 91,479 shares, $8,227,096 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 76.
- Largest priced transaction: sale of 25,787 shares @ $105.46 ($2,719,515) in Arcellx, Inc., filed 2024-11-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcellx, Inc. (ACLX) | Director | 23 | — | 32 legs · 91,479 sh · $8,227,096 | 51 |
| SelectQuote, Inc. (SLQT) | Director | 8 | — | — | 20 |
| Sigilon Therapeutics, Inc. (SGTX) | Director | 4 | — | — | 5 |
Insider filings — Patel Kavita
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | SelectQuote, Inc. (SLQT) | Option exercise (M): 106,250 @ $0 · Option exercise (M): 106,250 (derivative) @ $0 · Grant/award (A): 170,000 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | Arcellx, Inc. (ACLX) | Disposition to issuer (D): 27,077 (derivative) · Disposition to issuer (D): 20,513 (derivative) · Disposition to issuer (D): 11,459 (derivative) · Disposition to issuer (D): 8,011 (derivative) · Disposition to issuer (D): 9,174 (derivative) | EDGAR |
| 2025-11-13 | 4 | SelectQuote, Inc. (SLQT) | Option exercise (M): 52,631 @ $0 · Option exercise (M): 52,631 (derivative) @ $0 · Grant/award (A): 106,250 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,500 @ $67.36 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Arcellx, Inc. (ACLX) | Grant/award (A): 9,174 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,500 @ $58.43 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2025-04-29 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,500 @ $64.20 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,500 @ $57.50 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,500 @ $71.64 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,500 @ $63.16 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,500 @ $64.57 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2025-01-14 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 800 @ $64.95 · Sale (S): 400 @ $66.62 · Sale (S): 300 @ $67.32 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-12-05 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 300 @ $88.53 · Sale (S): 400 @ $89.84 · Sale (S): 200 @ $91.91 · Sale (S): 300 @ $93.76 · Sale (S): 300 @ $96.05 · +1 more | EDGAR |
| 2024-11-14 | 4 | SelectQuote, Inc. (SLQT) | Option exercise (M): 94,890 @ $0 · Option exercise (M): 94,890 (derivative) @ $0 · Grant/award (A): 52,631 (derivative) @ $0 | EDGAR |
| 2024-11-14 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,500 @ $106.33 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 8,478 @ $6.66 · Sale (S): 8,478 @ $99.30 · Option exercise (M): 7,976 @ $6.66 · Option exercise (M): 25,787 @ $15 · Sale (S): 5,900 @ $99.60 · Sale (S): 2,076 @ $100.57 · +8 more | EDGAR |
| 2024-10-22 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,500 @ $89.69 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,500 @ $82.24 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-09-12 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,500 @ $74.41 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,500 @ $65.88 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-08-01 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 1,300 @ $61.81 · Sale (S): 200 @ $62.95 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-07-11 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 1,500 @ $6.66 · Sale (S): 852 @ $56.23 · Sale (S): 648 @ $57.15 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Arcellx, Inc. (ACLX) | Option exercise (M): 10,000 @ $6.66 · Sale (S): 4,971 @ $54.02 · Sale (S): 5,029 @ $54.51 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Arcellx, Inc. (ACLX) | Grant/award (A): 8,011 (derivative) @ $0 | EDGAR |
| 2023-11-16 | 4 | SelectQuote, Inc. (SLQT) | Option exercise (M): 203,125 @ $0 · Option exercise (M): 203,125 (derivative) @ $0 · Grant/award (A): 94,890 (derivative) @ $0 | EDGAR |
| 2023-08-11 | 4 | Sigilon Therapeutics, Inc. (SGTX) | Disposition to issuer (D): 683 (derivative) @ $6.64 · Disposition to issuer (D): 683 (derivative) @ $5.00 | EDGAR |
| 2023-06-16 | 4 | Arcellx, Inc. (ACLX) | Grant/award (A): 11,459 (derivative) @ $0 | EDGAR |
| 2023-05-22 | 4 | Sigilon Therapeutics, Inc. (SGTX) | Grant/award (A): 8,888 (derivative) @ $0 | EDGAR |
| 2022-11-17 | 4 | SelectQuote, Inc. (SLQT) | Option exercise (M): 7,849 @ $0 · Grant/award (A): 203,125 (derivative) @ $0 · Option exercise (M): 7,849 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | Sigilon Therapeutics, Inc. (SGTX) | Grant/award (A): 8,888 (derivative) @ $0 | EDGAR |
| 2022-02-07 | 4 | Arcellx, Inc. (ACLX) | Grant/award (A): 61,538 (derivative) @ $0 | EDGAR |
| 2021-12-09 | 4 | SelectQuote, Inc. (SLQT) | Option exercise (M): 4,719 @ $0 · Option exercise (M): 4,719 (derivative) @ $0 | EDGAR |
| 2021-11-15 | 4 | SelectQuote, Inc. (SLQT) | Grant/award (A): 7,849 (derivative) @ $0 | EDGAR |
| 2021-06-28 | 4 | Sigilon Therapeutics, Inc. (SGTX) | Grant/award (A): 8,888 (derivative) @ $9.97 | EDGAR |
| 2020-12-11 | 4 | SelectQuote, Inc. (SLQT) | Grant/award (A): 4,719 (derivative) @ $0 · Grant/award (A): 23,596 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1670683 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs